These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 32562020

  • 1. Polymyalgia Rheumatica: a Common Disease in Seniors.
    Gazitt T, Zisman D, Gardner G.
    Curr Rheumatol Rep; 2020 Jun 19; 22(8):40. PubMed ID: 32562020
    [Abstract] [Full Text] [Related]

  • 2. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 3. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 4. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 14; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 5. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH.
    Prim Care; 2018 Jun 14; 45(2):305-323. PubMed ID: 29759126
    [Abstract] [Full Text] [Related]

  • 6. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis.
    Nageswaran P, Ahmed S, Tahir H.
    Expert Opin Emerg Drugs; 2024 Mar 14; 29(1):5-17. PubMed ID: 38180809
    [Abstract] [Full Text] [Related]

  • 7. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
    Hysa E, Casabella A, Gotelli E, Campitiello R, Schenone C, Genova C, Tanda ET, Sulli A, Smith V, Cimmino MA, Paolino S, Cutolo M.
    Autoimmun Rev; 2024 Mar 14; 23(7-8):103589. PubMed ID: 39117006
    [Abstract] [Full Text] [Related]

  • 8. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG.
    J Rheumatol; 2000 Sep 14; 27(9):2179-84. PubMed ID: 10990231
    [Abstract] [Full Text] [Related]

  • 9. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA, Pina T.
    Curr Rheumatol Rep; 2015 Feb 14; 17(2):6. PubMed ID: 25618572
    [Abstract] [Full Text] [Related]

  • 10. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K.
    FP Essent; 2016 Jan 14; 440():16-22. PubMed ID: 26734832
    [Abstract] [Full Text] [Related]

  • 11. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Pipitone N, Versari A, Hunder GG.
    Nat Rev Rheumatol; 2012 Sep 14; 8(9):509-21. PubMed ID: 22825731
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and management of polymyalgia rheumatica.
    Jones O, Birrell F.
    Practitioner; 2016 Dec 14; 260(1799):13-6. PubMed ID: 29020715
    [Abstract] [Full Text] [Related]

  • 13. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA, Bijlsma JW, Derksen RH.
    Ned Tijdschr Geneeskd; 2005 Aug 27; 149(35):1932-7. PubMed ID: 16159030
    [Abstract] [Full Text] [Related]

  • 14. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec 27; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 15. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B.
    Autoimmun Rev; 2024 Jan 27; 23(1):103415. PubMed ID: 37625672
    [Abstract] [Full Text] [Related]

  • 16. An update on polymyalgia rheumatica.
    Lundberg IE, Sharma A, Turesson C, Mohammad AJ.
    J Intern Med; 2022 Nov 27; 292(5):717-732. PubMed ID: 35612524
    [Abstract] [Full Text] [Related]

  • 17. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    Vieira M, Comarmond C, Labreuche J, Mirouse A, Saadoun D, Richez C, Flipo RM, Hachulla E, Drumez E, Cacoub P, FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.
    J Autoimmun; 2022 Oct 27; 132():102868. PubMed ID: 35926375
    [Abstract] [Full Text] [Related]

  • 18. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A, Montecucco CM, Caporali R, Cavagna L, Montagna P, Capellino S, Fazzuoli L, Seriolo B, Alessandro C, Secchi ME, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun 27; 1069():307-14. PubMed ID: 16855158
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune Conditions: Polymyalgia Rheumatica and Dermatomyositis.
    Ghetu MV.
    FP Essent; 2020 Jul 27; 494():25-29. PubMed ID: 32640151
    [Abstract] [Full Text] [Related]

  • 20. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE, Harris E, Mathieson H, Sorensen L, Luqmani R, McGettrick HM, Morgan AW, Young SP, Mackie SL.
    J Autoimmun; 2024 Jul 27; 147():103260. PubMed ID: 38797046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.